Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib Read more
H3 Biomedicine Extends Collaboration with Foundation Medicine to Develop Precision Therapies for Cancer Read more
Japan’s Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories Read more